stella
beta
Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations — Stella
Home
/
Cerebral AV Malformation
/
View on ClinicalTrials.gov
Recruiting
Back to Cerebral AV Malformation trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
France
HFAR, Paris, Île-de-France Region